Camptothecin

tumor protein p53 ; Homo sapiens







103 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35192728 Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance. 2022 Mar 1
2 31482012 Transcription-independent and -dependent p53-mediated apoptosis in response to genotoxic and non-genotoxic stress. 2019 6
3 29684847 The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study. 2018 Jun 3
4 29875999 Transcriptional activation of p21Waf1 contributes to suppression of HR by p53 in response to replication arrest induced by camptothecin. 2018 May 22 1
5 30096294 PIM2 survival kinase is upregulated in a p53-dependent manner in cells treated with camptothecin or co-treated with actinomycin D and nutlin-3a. 2018 Oct 1 1
6 28361991 Y14 governs p53 expression and modulates DNA damage sensitivity. 2017 Mar 31 1
7 29137250 Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation. 2017 Oct 10 1
8 26252178 Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20. 2015 1
9 26437226 Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design. 2015 Nov 3 1
10 24726431 SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. 2014 Jun 15 1
11 24786831 Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response. 2014 Sep 1
12 24858802 Autophagy inhibition switches low-dose camptothecin-induced premature senescence to apoptosis in human colorectal cancer cells. 2014 Aug 1 2
13 24996846 γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments. 2014 Jul 4 1
14 23006513 Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors. 2013 Jan 1
15 23161404 Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y cells. 2013 Mar 2
16 23208500 Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells. 2013 Oct 24 1
17 23313858 Sirt1 attenuates camptothecin-induced apoptosis through caspase-3 pathway in porcine preadipocytes. 2013 Mar 10 2
18 23470959 DDX3 regulates DNA damage-induced apoptosis and p53 stabilization. 2013 Jun 4
19 23536184 The Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugs. 2013 May 10 1
20 24219989 Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress. 2013 Dec 11 2
21 20812030 Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1. 2011 Jan 2
22 21145583 Activation of stress-regulated transcription factors by triethylene glycol dimethacrylate monomer. 2011 Mar 3
23 21809047 Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells. 2011 Nov 1
24 19629643 Differential regulation of Apak by various DNA damage signals. 2010 Jan 2
25 20042274 ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968. 2010 Jun 28 1
26 20086182 The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. 2010 Feb 1
27 20429622 Dual inhibition of topoisomerases enhances apoptosis in melanoma cells. 2010 1
28 20661218 Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells. 2010 Oct 14 1
29 20662736 Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2. 2010 Aug 2
30 20978201 DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue. 2010 Nov 1 1
31 19049493 The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP). 2009 Mar 15 1
32 19060337 Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control. 2009 Feb 13 1
33 19261878 Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. 2009 Mar 4 2
34 19445707 Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent. 2009 May 16 3
35 18208837 Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. 2008 Mar 1
36 18418047 A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. 2008 May 1 1
37 18495890 CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage. 2008 May 21 1
38 17255282 CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. 2007 Jan 15 1
39 17317670 Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. 2007 Apr 20 1
40 17555331 Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. 2007 Jul 3 1
41 17709397 Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways. 2007 Oct 2
42 16319068 Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. 2006 Feb 3 1
43 16407843 p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine. 2006 May 11 2
44 15674334 Tumor suppressor p53 represses transcription of RECQ4 helicase. 2005 Mar 3 2
45 15846088 Inhibition of p53 by lentiviral mediated shRNA abrogates G1 arrest and apoptosis in retinal pigmented epithelial cell line. 2005 May 1
46 15908423 A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells. 2005 Jul 22 1
47 15958570 Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress. 2005 Jun 15 1
48 15149862 Distinct functions for WRN and TP53 in a shared pathway of cellular response to 1-beta-D-arabinofuranosylcytosine and bleomycin. 2004 Jun 10 1
49 15208667 p53-dependent transcription can exhibit both on/off and graded response after genotoxic stress. 2004 Aug 19 1
50 15371552 Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates. 2004 1